Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Family History App in Personalized Medicine [NA]
An update on a university-sponsored clinical trial evaluating a family history app for personalized medicine; the study is currently active …
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers [NA]
This clinical trial update describes a study evaluating early salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers to assess…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer [Phase 1, Phase 2]
This entry notes a Phase 1/Phase 2 clinical trial combining fuzuloparib with arsenic trioxide for platinum-resistant relapsed ovarian cancer…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer
This is a prospective multicenter diagnostic biomarker study designed to discriminate borderline ovarian tumors from stage I invasive ovaria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC [Phase 2]
Phase 2 trial assessing OSE2101 alone or in combination with pembrolizumab versus best supportive care in patients with platinum-sensitive o…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]
A Phase 2 trial is evaluating pamiparib combined with surufatinib as neoadjuvant therapy for unresectable ovarian cancer. The study is curre…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of surufatinib combined with carboplatin/paclitaxel and with olaparib as first-line and…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Fluzoparib Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 clinical trial update shows fluzoparib as neoadjuvant therapy for ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Establishment and Clinical Application of AI-based Multimodal Diagnosis System for Ovarian Tumors [NA]
A trial update reports the establishment and clinical application of an AI-based multimodal diagnostic system for ovarian tumors, with the s…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer [NA]
This clinical trial is evaluating sentinel lymph node biopsy for early-stage ovarian cancer and is currently recruiting at Istanbul Universi…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
This clinical trial update outlines an ongoing audit of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) sponsor…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
This clinical trials registry entry reports the development and validation of a prediction model for acute kidney injury after cisplatin-bas…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: High Definition Profiling of Ovarian Cancer Ascites
Update on a clinical trial evaluating high-definition profiling of ovarian cancer ascites; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: HOT: HIPEC in Ovarian Cancer as Initial Treatment [Phase 2]
Phase 2 trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) as initial treatment for Stage III/IV ovarian cancer is currently…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age
A pediatric ovarian tissue banking trial is currently recruiting females aged 0-18, collecting operative specimens for conditions including …
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
This document provides an update on a Phase 1 trial evaluating autologous CAR T cells in patients with advanced, platinum-resistant ovarian,…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer
A clinical trial update focusing on validating the KELIM metric as a predictive and prognostic biomarker for maintenance PARP inhibitor ther…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer. [EARLY_Phase 1]
This is an early-phase exploratory study evaluating the safety and potential efficacy of Disitamab Vedotin in combination with Anlotinib Hyd…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial [NA]
This document provides an update on the DISC-OVARY trial, which investigates a 3D bioprinted hormone-producing model for BRCA mutation carri…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study [Phase 2]
A Phase 2 neoadjuvant trial evaluating Olaparib in ovarian cancer (Stage IV) is currently not recruiting.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
This clinical trial update notes a real-world evidence study in Poland evaluating niraparib maintenance therapy for newly diagnosed advanced…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients [Phase 2]
This entry notes a Phase 2 clinical trial evaluating SSGJ-707 in advanced or recurrent gynecologic cancers, including endometrial cancer and…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer [Phase 3]
This Clinical Trials update reports a Phase 3 study evaluating chiauranib in combination with weekly paclitaxel for platinum-refractory or p…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
This clinical trial is evaluating an ultrasensitive surface-enhanced Raman spectroscopy (SERS) platform with efficient enrichment of analyte…